Shelby Giza

Employment

• Space Tango Director, Business Development - Applications
  2024 - Present
• Space Tango Director, Scientific Business Strategy
  2023 - 2024
• Space Tango Director, Science
  2021 - 2023
• University of Florida Biological Scientist
  2019 - 2021
• Alopexx Enterprises, LLC PK Clinical Scientist
  2018 - 2019
• Novartis Institutes for BioMedical Research Inc Scientist
  2013 - 2018
• Novartis Institutes for BioMedical Research Inc Scientist
  2007 - 2013
• Boston Scientific Corporation Scientist
  2004 - 2007
• RenaMed Biologics Manufacturing Technician
  2004 - 2004
• Dana-Farber Cancer Institute Scientist
  2002 - 2004

Education

• Syracuse University Master of Business Administration
  2025 - Present
• University of Massachusetts Dartmouth Bachelor of Science
  1996 - 2001

Projects & Funding

Projects & funding information is unavailable.

Publications (15)

• Multi-omics and spatial analysis of microgravity-grown glioblastoma organoids reveals superior modeling of advanced disease after long-term spaceflight
  2026 DOI: 10.64898/2026.03.06.710192
  +Save
• Comparative Analysis of Matrigel and Tunable Collagen‐Fibrin Blends for in Vitro Skeletal Muscle Models
  Journal of Biomedical Materials Research Part A 2026 DOI: 10.1002/jbma.70039
  +Save
• Nanobioreactor detection of space-associated hematopoietic stem and progenitor cell aging
  Cell Stem Cell 2025 DOI: 10.1016/j.stem.2025.07.013
  +Save
• Human skeletal muscle tissue chip autonomous payload reveals changes in fiber type and metabolic gene expression due to spaceflight
  npj Microgravity 2023 DOI: 10.1038/s41526-023-00322-y
  +Save
• Microphysiological system for studying contractile differences in young, active, and old, sedentary adult derived skeletal muscle cells
  Aging Cell 2022 DOI: 10.1111/acel.13650
  +Save
• Lack of involvement of CEP adducts in TLR activation and in angiogenesis
  PLoS ONE 2014 DOI: 10.1371/journal.pone.0111472
  +Save
• Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion.
  Clinical cancer research : an official journal of the American Association for Cancer Research 2010 DOI: 10.1158/1078-0432.ccr-10-0415
  +Save
• Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis.
  British journal of haematology 2007 DOI: 10.1111/j.1365-2141.2007.06803.x
  +Save
• Mixed Hematopoietic Chimerism for Sickle Cell Disease Prevents Intravascular Hemolysis and Corrects Biomarkers of Endothelial Function.
  Blood 2005 DOI: 10.1182/blood.v106.11.2333.2333
  +Save
• Evidence for ineffective erythropoiesis in severe sickle cell disease.
  Blood 2005 DOI: 10.1182/blood-2005-04-1376
  +Save